Research Information Only
This information is provided for educational purposes only. Tesamorelin (Egrifta) should only be used under medical supervision. Always consult with qualified healthcare professionals before considering any compound.
Growth Hormone
Tesamorelin (Egrifta)
FDA-approved GHRH analog for reducing visceral fat.
Recommended for those interested in fda-approved ghrh analog for reducing visceral fat.
Research Areas
Lipodystrophy
Visceral fat reduction
Protocol Details
Research Dose:
███████████
Frequency:
█████████
Timing:
████████████
Cycle:
██████████
Primary: ████████
Reconstitution: █████████████
Storage: ██████████
Premium Feature
Protocol details including dosing, timing, and administration are available to Premium members.
Upgrade to PremiumPotential Side Effects
- • Injection site reactions
- • Joint pain
- • Water retention
Contraindications
- Active cancer
- Pituitary disease